The global nasal
cannula market by Product Type (Low-flow Cannula, High-flow Cannula, and
Others), by Application (Cancer, Respiratory Diseases , Cardiovascular
Diseases, and Others), by End User (Hospitals, Neonatal Intensive Care Units,
Home Care Settings, and Others), and by Region (North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 4,234.5
million in 2017, and is projected to exhibit a CAGR of 7.4% over the forecast
period (2018–2026).
The global nasal cannula market
is expected to witness significant growth over the forecast period, owing to
factors such as product development and high prevalence of diseases including
chronic obstructive pulmonary respiratory diseases (COPD), lung cancer, and
stroke. Moreover, initiatives taken by several organizations related to
treatment and awareness of respiratory diseases is expected to support the
global nasal cannula market growth over the forecast period. Manufacturers are
focusing on developing new products and introducing new technology in the
market. For instance, in January 2016, UODPS LLC launched a product: Uniflo-2
single nasal cannula, which was designed using ultra-smooth materials. It does
not contain any rubber latex, which minimizes the exposure to Di-2-ethylhexyl
phthalate (DEHP), thereby preventing irritation. It consists of memory
stabilizer and ensures continuous flow of air. In June 2018, the company
conducted a survey wherein opinions were recorded from COPD patients using
Uniflo 2 single nasal cannula.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2694
The study revealed that almost
98% patients found this cannula as more comforting than dual prong nasal
cannula. It allows minimum skin contact so as to avoid skin irritation, which
occurs in dual prongs and is almost half in weight as compared to dual prong
nasal cannulas. Moreover, in October 2018, Vapotherm Inc. received an approval
from the U.S. Food and Drug Administration (FDA) for Precision Flow Hi-VNI
system (respiratory system), which involves designed nasal cannulas that assist
high flow oxygen therapy.
Browse 26 Market Data Tables and
32 Figures spread through 168 Pages and in-depth TOC on Global Nasal Cannula
Market by Product Type (Low-flow Cannula, High-flow Cannula, and Others), by
Application (Cancer, Respiratory Diseases, Cardiovascular Diseases, and
Others), by End User (Hospitals, Neonatal Intensive Care Units, Home Care
Settings, and Others), and by Region (North America, Latin America, Europe,
Asia Pacific, Middle East, and Africa) - Global Forecast to 2026
High prevalence of COPD may lead
to increasing demand for nasal cannula, thereby boosting the global nasal
cannula market growth over the forecast period. According to World Health
Organization (WHO), approximately 65 million people suffer from moderate to
severe COPD and around 3 million deaths are recorded every year globally.
Moreover, COPD is the third leading cause of death worldwide. According to the
same source, acute lower respiratory tract infections are responsible for
around 4 million deaths in children aged less than 5 years, worldwide annually.
Moreover, preterm infants are associated with complications related to breathing
difficulties. According to WHO, in 2018, approximately 15 million infants were
born premature, worldwide. Nasal cannula can be used to give an accurate amount
of airflow to children. Therefore, increasing prevalence of COPD in children
and adults is expected to drive the global nasal cannula market growth over the
forecast period.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/nasal-cannula-market-2694
Key Takeaways of the Global Nasal
Cannula Market:
The global nasal cannula market
is expected to exhibit a CAGR of 4% over the forecast period (2018–2026), due
to vast number of products offered by manufacturers, which broadens the range
of available options to customers
Increasing prevalence of diseases
such as lung cancer, stroke, and COPD may lead to high demand for nasal
cannulas, thereby supporting the global nasal cannula market growth over the
forecast period
Major players operating in the
global nasal cannula market include, Sunset Healthcare Solutions Inc.,
Flexicare Ltd., medin Medical Innovations GmbH, Salter Labs, Smiths Medical,
Teleflex Inc., Neotech Products, Fairmont Medical, Medline Industries Inc., and
Hamilton Medicals
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2694
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment